Catherine Harmer

• Vortioxetine reduces BOLD signal during performance of the N-back working memory task: a randomised neuroimaging trial in remitted depressed patients and healthy controls.

  Smith J. et al, (2017), Mol Psychiatry

• Variation in the recall of socially rewarding information and depressive symptom severity: a prospective cohort study.

  Lewis G. et al, (2017), Acta Psychiatr Scand, 135, 489 - 498

• How do antidepressants work? New perspectives for refining future treatment approaches.

  Harmer CJ. et al, (2017), Lancet Psychiatry, 4, 409 - 418

• Differences in neural and cognitive response to emotional faces in middle-aged dizygotic twins at familial risk of depression.

  Miskowiak KW. et al, (2017), Psychol Med, 1 - 13

• The effects of medication and current mood upon facial emotion recognition: findings from a large bipolar disorder cohort study.

  Bilderbeck AC. et al, (2017), J Psychopharmacol, 31, 320 - 326

• Beyond negative valence: 2-week administration of a serotonergic antidepressant enhances both reward and effort learning signals.

  Scholl J. et al, (2017), PLoS Biol, 15

• Excitation and inhibition in anterior cingulate predict use of past experiences.

  Scholl J. et al, (2017), Elife, 6

• Differential activation of the frontal pole to high vs low calorie foods: The neural basis of food preference in Anorexia Nervosa?

  Scaife JC. et al, (2016), Psychiatry Res, 258, 44 - 53

• Fronto-limbic effective connectivity as possible predictor of antidepressant response to SSRI administration.

  Vai B. et al, (2016), Eur Neuropsychopharmacol, 26, 2000 - 2010

• Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression.

  Godlewska BR. et al, (2016), Transl Psychiatry, 6

• Test-retest reliability and task order effects of emotional cognitive tests in healthy subjects.

  Adams T. et al, (2016), Cogn Emot, 30, 1247 - 1259

• Oxytocin and emotion processing.

  Di Simplicio M. and Harmer CJ., (2016), J Psychopharmacol, 30, 1156 - 1159

• Associations between mood instability and emotional processing in a large cohort of bipolar patients.

  Bilderbeck AC. et al, (2016), Psychol Med, 46, 3151 - 3160

• The NMDA receptor partial agonist d-cycloserine does not enhance motor learning.

  Günthner J. et al, (2016), J Psychopharmacol, 30, 994 - 999

• Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders.

  Miskowiak KW. et al, (2016), Acta Psychiatr Scand, 134, 249 - 259

• Assessment of automatic associations with bodily sensations and agoraphobic situations in panic disorder.

  Woud ML. et al, (2016), J Behav Ther Exp Psychiatry, 52, 105 - 109

• Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing.

  Masaki C. et al, (2016), Psychopharmacology (Berl), 233, 2655 - 2661

• Neural correlates of improved executive function following erythropoietin treatment in mood disorders.

  Miskowiak KW. et al, (2016), Psychol Med, 46, 1679 - 1691

• Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans.

  Singh N. et al, (2016), Neuropsychopharmacology, 41, 1768 - 1778

• Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate.

  Downey D. et al, (2016), Eur Neuropsychopharmacol, 26, 994 - 1003

• Cognitive mechanisms of diazepam administration: a healthy volunteer model of emotional processing.

  Pringle A. et al, (2016), Psychopharmacology (Berl), 233, 2221 - 2228

• A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies.

  Post A. et al, (2016), Neuropsychopharmacology, 41, 1803 - 1812

• Frontal Cortex Stimulation Reduces Vigilance to Threat: Implications for the Treatment of Depression and Anxiety.

  Ironside M. et al, (2016), Biol Psychiatry, 79, 823 - 830

• SSRI enhances sensitivity to background outcomes and modulates response rates: A randomized double blind study of instrumental action and depression.

  Msetfi RM. et al, (2016), Neurobiol Learn Mem, 131, 76 - 82

• Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial.

  Saunders KE. et al, (2016), Trials, 17

• Vulnerability for new episodes in recurrent major depressive disorder: protocol for the longitudinal DELTA-neuroimaging cohort study.

  Mocking RJ. et al, (2016), BMJ Open, 6

• Effects of short-term quetiapine treatment on emotional processing, sleep and circadian rhythms.

  Rock PL. et al, (2016), J Psychopharmacol, 30, 273 - 282

• Innovative approaches to bipolar disorder and its treatment.

  Harrison PJ. et al, (2016), Ann N Y Acad Sci, 1366, 76 - 89

• Effects of the pattern of glucocorticoid replacement on neural processing, emotional reactivity and well-being in healthy male individuals: study protocol for a randomised controlled trial.

  Kalafatakis K. et al, (2016), Trials, 17

• Hippocampal volume in vulnerability and resilience to depression.

  Chan SW. et al, (2016), J Affect Disord, 189, 199 - 202

• A single dose of mirtazapine attenuates neural responses to self-referential processing.

  Komulainen E. et al, (2016), J Psychopharmacol, 30, 23 - 32

• The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment.

  Pringle A. and Harmer CJ., (2015), Dialogues Clin Neurosci, 17, 477 - 487

• Testing the antidepressant properties of the peptide ARA290 in a human neuropsychological model of drug action.

  Cerit H. et al, (2015), Eur Neuropsychopharmacol, 25, 2289 - 2299

• Effective emotion regulation strategies improve fMRI and ECG markers of psychopathology in panic disorder: implications for psychological treatment action.

  Reinecke A. et al, (2015), Transl Psychiatry, 5

• Does melatonin treatment change emotional processing? Implications for understanding the antidepressant mechanism of agomelatine.

  Pringle A. et al, (2015), J Psychopharmacol, 29, 1129 - 1132

• A neurocognitive model for understanding treatment action in depression.

  Warren MB. et al, (2015), Philos Trans R Soc Lond B Biol Sci, 370

• Vortioxetine reduces BOLD signal during performance of the N-back task in subjects remitted from depression and healthy control participants

  Browning M. et al, (2015), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 25, S314 - S315

• Fronto-limbic connectivity in depression predicts response to SSRI administration

  Vai B. et al, (2015), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 25, S444 - S444

• The Good, the Bad, and the Irrelevant: Neural Mechanisms of Learning Real and Hypothetical Rewards and Effort.

  Scholl J. et al, (2015), J Neurosci, 35, 11233 - 11251

• The cognitive neuropsychological model of antidepressant response

  Walsh AEL. and Harmer CJ., (2015), Current Opinion in Psychology, 4, 124 - 130

• Acute fluoxetine modulates emotional processing in young adult volunteers.

  Capitão LP. et al, (2015), Psychol Med, 45, 2295 - 2308

• Rationale and design of OxLith: a randomised placebo controlled trial exploring the short-term physical and psychological effects of lithium on mood instability

  Geddes JR. et al, (2015), BIPOLAR DISORDERS, 17, 110 - 110

• Effects of seven-day diazepam administration on resting-state functional connectivity in healthy volunteers: A randomized, double-blind study

  Pflanz CP. et al, (2015), Psychopharmacology, 232, 2139 - 2147

• Effects of seven-day diazepam administration on resting-state functional connectivity in healthy volunteers: a randomized, double-blind study.

  Pflanz CP. et al, (2015), Psychopharmacology (Berl), 232, 2139 - 2147

• Daily and weekly mood ratings: relative contributions to the differentiation of bipolar disorder and borderline personality disorder

  Bilderbeck AC. et al, (2015), BIPOLAR DISORDERS, 17, 129 - 130

• Association between mood variability and emotional processing among individuals diagnosed with bipolar disorder

  Bilderbeck AC. et al, (2015), BIPOLAR DISORDERS, 17, 111 - 111

• Acceptability and tolerability of ambulatory monitoring in bipolar disorder: a patient perspective

  Saunders K. et al, (2015), BIPOLAR DISORDERS, 17, 86 - 86

• Tianeptine in an experimental medicine model of antidepressant action.

  Cooper CM. et al, (2015), J Psychopharmacol, 29, 582 - 590

• Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers

  Schmidt K. et al, (2015), Psychopharmacology, 232, 1793 - 1801

• Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers.

  Schmidt K. et al, (2015), Psychopharmacology (Berl), 232, 1793 - 1801

• Different neural and cognitive response to emotional faces in healthy monozygotic twins at risk of depression.

  Miskowiak KW. et al, (2015), Psychol Med, 45, 1447 - 1458

• Satiation attenuates BOLD activity in brain regions involved in reward and increases activity in dorsolateral prefrontal cortex: an fMRI study in healthy volunteers.

  Thomas JM. et al, (2015), Am J Clin Nutr, 101, 697 - 704

• Meta-analysis of emotion recognition deficits in major depressive disorder.

  Dalili MN. et al, (2015), Psychol Med, 45, 1135 - 1144

• How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia.

  Freeman D. et al, (2015), Schizophr Bull, 41, 391 - 399

• Early effects of tianeptine on emotional processing in healthy volunteers

  Cooper CM. et al, (2015), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 25, S68 - S69

• Cognitive vulnerability and implicit emotional processing: imbalance in frontolimbic brain areas?

  Groenewold NA. et al, (2015), Cogn Affect Behav Neurosci, 15, 69 - 79

• Meta-analysis of emotion recognition deficits in major depressive disorder

  Dalili MN. et al, (2015), Psychological Medicine, 45, 1135 - 1144

• Different neural and cognitive response to emotional faces in healthy monozygotic twins at risk of depression

  Miskowiak KW. et al, (2015), Psychological Medicine, 45, 1447 - 1458

• Anxiety increases breakthrough of threat stimuli in continuous flash suppression.

  Capitão LP. et al, (2014), Emotion, 14, 1027 - 1036

• 'Can you look me in the face?' Short-term SSRI administration reverts avoidant ocular face exploration in subjects at risk for psychopathology.

  Di Simplicio M. et al, (2014), Neuropsychopharmacology, 39, 3059 - 3066

• Predicting rapid response to cognitive-behavioural treatment for panic disorder: The role of hippocampus, insula, and dorsolateral prefrontal cortex

  Reinecke A. et al, (2014), Behaviour Research and Therapy, 62, 120 - 128

• Predicting rapid response to cognitive-behavioural treatment for panic disorder: the role of hippocampus, insula, and dorsolateral prefrontal cortex.

  Reinecke A. et al, (2014), Behav Res Ther, 62, 120 - 128

• Opposing neural effects of naltrexone on food reward and aversion: implications for the treatment of obesity.

  Murray E. et al, (2014), Psychopharmacology (Berl), 231, 4323 - 4335

• A role beyond learning for NMDA receptors in reward-based decision-making-a pharmacological study using d-cycloserine.

  Scholl J. et al, (2014), Neuropsychopharmacology, 39, 2900 - 2909

• Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers

  Schmidt K. et al, (2014), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 24, S191 - S191

• Effects of short-term diazepam administration on resting-state functional connectivity in healthy adults

  Pflanz CP. et al, (2014), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 24, S311 - S311

• Effects of agomelatine compared to escitalopram on motivation in healthy male and female volunteers after 9 weeks of treatment

  Gaillard R. et al, (2014), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 24, S458 - S459

• Better sexual acceptability of agomelatine compared to escitalopram in healthy volunteers during a 9-week placebo-controlled trial

  Montejo AL. et al, (2014), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 24, S454 - S455

• Executive dysfunction and autobiographical memory retrieval in recovered depressed women.

  Haddad AD. et al, (2014), J Behav Ther Exp Psychiatry, 45, 260 - 266

• Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial.

  Miskowiak KW. et al, (2014), Neuropsychopharmacology, 39, 1399 - 1408

• Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers

  Schmidt K. et al, (2014), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 24, S74 - S74

• Altered neural activation by emotion regulation and reduced startle response in healthy volunteers after subchronic diazepam treatment

  Gottwald J. et al, (2014), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 24, S80 - S80

• Increasing pharmacological knowledge about human neurological and psychiatric disorders through functional neuroimaging and its application in drug discovery.

  Nathan PJ. et al, (2014), Curr Opin Pharmacol, 14, 54 - 61

• Recombinant human erythropoietin for treating treatment-resistant depression: A double-blind, randomized, placebo-controlled phase 2 trial

  Miskowiak KW. et al, (2014), Neuropsychopharmacology, 39, 1399 - 1408

• Paradoxical effects of short-term antidepressant treatment in fMRI emotional processing models in volunteers with high neuroticism.

  Di Simplicio M. et al, (2014), Psychol Med, 44, 241 - 252

• Effects of short-term varenicline administration on cortisol in healthy, non-smoking adults: a randomized, double-blind, study.

  Mocking RJ. et al, (2014), Psychopharmacology (Berl), 231, 143 - 148

• EFFECTS OF AGOMELATINE AND ESCITALOPRAM ON EMOTIONAL DETACHMENT, EMOTIONAL PROCESSING AND MOTIVATION DURING A 9-WEEK TREATMENT IN HEALTHY VOLUNTEERS

  Goodwin GM. et al, (2014), EUROPEAN PSYCHIATRY, 29

• Anxiety increases breakthrough of threat stimuli in continuous flash suppression

  Capitão LP. et al, (2014), Emotion, 14, 1027 - 1036

• A sense of embodiment is reflected in people's signature size.

  Rawal A. et al, (2014), PLoS One, 9

• A role beyond learning for NMDA receptors in reward-based decision-making - A pharmacological study using d-cycloserine

  Scholl J. et al, (2014), Neuropsychopharmacology, 39, 2900 - 2909

• Early markers of cognitive enhancement: developing an implicit measure of cognitive performance.

  Pringle A. et al, (2013), Psychopharmacology (Berl), 230, 631 - 638

• Early Changes in Neural Responses to Emotional Information Predict Clinical Response to SSRI Treatment in Depression

  Godlewska B. et al, (2013), NEUROPSYCHOPHARMACOLOGY, 38, S446 - S446

• Quetiapine's effects on emotional processing and sleep oppose abnormalities seen in bipolar phenotype

  Rock PL. et al, (2013), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 23, S381 - S382

• Short-term quetiapine treatment alters the use of reinforcement signals during risky decision-making and promotes the choice of negative expected values in healthy adult males.

  Rock PL. et al, (2013), J Neurosci, 33, 15588 - 15595

• 'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression.

  Harmer CJ. and Cowen PJ., (2013), Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 368

• Neuroimaging Approaches to the Understanding of Depression and the Identification of Novel Antidepressants

  Kumar P. et al, (2013), Translational Neuroimaging, 343 - 411

• Antidepressant treatment and emotional processing: can we dissociate the roles of serotonin and noradrenaline?

  Pringle A. et al, (2013), J Psychopharmacol, 27, 719 - 731

• Effects of pramipexole on the processing of rewarding and aversive taste stimuli

  McCabe C. et al, (2013), Psychopharmacology, 228, 283 - 290

• Effects of pramipexole on the processing of rewarding and aversive taste stimuli.

  McCabe C. et al, (2013), Psychopharmacology (Berl), 228, 283 - 290

• Effects of emotion recognition training on mood among individuals with high levels of depressive symptoms: study protocol for a randomised controlled trial.

  Adams S. et al, (2013), Trials, 14

• Changes in automatic threat processing precede and predict clinical changes with exposure-based cognitive-behavior therapy for panic disorder.

  Reinecke A. et al, (2013), Biol Psychiatry, 73, 1064 - 1070

• Impact of Quetiapine on Emotion Processing, Decision Making and Circadian Rhythms

  Rock PL. et al, (2013), BIOLOGICAL PSYCHIATRY, 73, 160S - 160S

• Executive Function in the Bipolar Phenotype

  Rock PL. and Harmer CJ., (2013), BIOLOGICAL PSYCHIATRY, 73, 159S - 160S

• Combined NK₁ antagonism and serotonin reuptake inhibition: effects on emotional processing in humans.

  Harmer CJ. et al, (2013), J Psychopharmacol, 27, 435 - 443

• The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: A meta-Analysis

  Murphy SE. et al, (2013), Molecular Psychiatry, 18, 512 - 520

• The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: A meta-Analysis

  Murphy SE. et al, (2013), Molecular Psychiatry, 18, 512 - 520

• The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: a meta-analysis.

  Murphy SE. et al, (2013), Mol Psychiatry, 18, 512 - 520

• Have no fear: the neural basis of anxiolytic drug action in generalized social phobia.

  Harmer CJ., (2013), Biol Psychiatry, 73, 300 - 301

• Effects of short-term varenicline administration on emotional and cognitive processing in healthy, non-smoking adults: a randomized, double-blind, study.

  Mocking RJ. et al, (2013), Neuropsychopharmacology, 38, 476 - 484

• Emotional processing and antidepressant action.

  Harmer CJ., (2013), Curr Top Behav Neurosci, 14, 209 - 222

• 'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression.

  Harmer CJ. and Cowen PJ., (2013), Philos Trans R Soc Lond B Biol Sci, 368

• Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients.

  Godlewska BR. et al, (2012), Psychol Med, 42, 2609 - 2617

• Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine.

  Pringle A. et al, (2012), J Psychopharmacol, 26, 1417 - 1423

• Using attentional bias modification as a cognitive vaccine against depression.

  Browning M. et al, (2012), Biol Psychiatry, 72, 572 - 579

• Neural processing of reward and punishment in young people at increased familial risk of depression.

  McCabe C. et al, (2012), Biol Psychiatry, 72, 588 - 594

• Neural processing of reward and punishment in young people at increased familial risk of depression

  McCabe C. et al, (2012), Biological Psychiatry, 72, 588 - 594

• Antidepressants and reward

  McCabe C. et al, (2012), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 22, S140 - S140

• Acute antidepressant drug administration and autobiographical memory recall: a functional magnetic resonance imaging study.

  Papadatou-Pastou M. et al, (2012), Exp Clin Psychopharmacol, 20, 364 - 372

• A single dose of the antidepressant fluoxetine modulates emotional processing in young adult volunteers

  Capitao LP. et al, (2012), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 22, S123 - S123

• "Look me in the facer!": short-term SSRI administration reverts avoidant ocular face exploration in subjects at risk for psychopathology

  Di Simplicio M. et al, (2012), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 22, S178 - S179

• Negative ion treatment increases positive emotional processing in seasonal affective disorder.

  Harmer CJ. et al, (2012), Psychol Med, 42, 1605 - 1612

• Decreased heart rate variability during emotion regulation in subjects at risk for psychopathology.

  Di Simplicio M. et al, (2012), Psychol Med, 42, 1775 - 1783

• Short-term antidepressant administration reduces negative self-referential processing in the medial prefrontal cortex in subjects at risk for depression.

  Di Simplicio M. et al, (2012), Mol Psychiatry, 17, 503 - 510

• Short-term antidepressant administration reduces negative self-referential processing in the medial prefrontal cortex in subjects at risk for depression

  Di Simplicio M. et al, (2012), Molecular Psychiatry, 17, 503 - 510

• Reply to: Punishing food: What brain activity can tell us about the representation of food in recovered anorexia nervosa

  Cowdrey FA. et al, (2012), Biological Psychiatry, 71

• Reply to: Punishing Food: What Brain Activity Can Tell Us About the Representation of Food in Recovered Anorexia Nervosa.

  Cowdrey FA. et al, (2012), Biol Psychiatry, 71

• A Week of Escitalopram Decreases Default Mode Network Activity in Dysphoric and Non-Dysphoric Participants

  Kumar P. et al, (2012), BIOLOGICAL PSYCHIATRY, 71, 199S - 199S

• Effects of low dose tryptophan depletion on emotional processing in dieters.

  Pringle A. et al, (2012), Eat Behav, 13, 154 - 157

• Neural responses to emotional faces in women recovered from anorexia nervosa

  Cowdrey FA. et al, (2012), Psychiatry Research - Neuroimaging, 201, 190 - 195

• Neural responses to emotional faces in women recovered from anorexia nervosa.

  Cowdrey FA. et al, (2012), Psychiatry Res, 201, 190 - 195

• Cognitive Bias Modification Using Mental Imagery for Depression: Developing a Novel Computerized Intervention to Change Negative Thinking Styles.

  Lang TJ. et al, (2012), Eur J Pers, 26, 145 - 157

• Cognitive Bias Modification Using Mental Imagery for Depression: Developing a Novel Computerized Intervention to Change Negative Thinking Styles

  Lang TJ. et al, (2012), European Journal of Personality, 26, 145 - 157

• Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

  Miskowiak KW. et al, (2012), Psychopharmacology (Berl), 219, 687 - 698

• Expectancy and surprise predict neural and behavioral measures of attention to threatening stimuli.

  Browning M. and Harmer CJ., (2012), Neuroimage, 59, 1942 - 1948

• Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine

  Pringle A. et al, (2012), JOURNAL OF PSYCHOPHARMACOLOGY, 26, 1417 - 1423

• Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing.

  Horder J. et al, (2012), J Psychopharmacol, 26, 125 - 132

• Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing

  Horder J. et al, (2012), JOURNAL OF PSYCHOPHARMACOLOGY, 26, 125 - 132

• Using an experimental medicine model to explore combination effects of pharmacological and cognitive interventions for depression and anxiety.

  Browning M. et al, (2011), Neuropsychopharmacology, 36, 2689 - 2697

• Neural response to angry and disgusted facial expressions in bulimia nervosa.

  Ashworth F. et al, (2011), Psychol Med, 41, 2375 - 2384

• Early morning cortisol response and emotional processing in adults exposed to postnatal depression in infancy.

  Douglas JL. and Harmer CJ., (2011), Eur Psychiatry, 26, 479 - 481

• Increased neural processing of rewarding and aversive food stimuli in recovered anorexia nervosa

  Cowdrey FA. et al, (2011), Biological Psychiatry, 70, 736 - 743

• Increased neural processing of rewarding and aversive food stimuli in recovered anorexia nervosa.

  Cowdrey FA. et al, (2011), Biol Psychiatry, 70, 736 - 743

• Neural correlates of the processing of self-referent emotional information in bulimia nervosa

  Pringle A. et al, (2011), Neuropsychologia, 49, 3272 - 3278

• Neural correlates of the processing of self-referent emotional information in bulimia nervosa.

  Pringle A. et al, (2011), Neuropsychologia, 49, 3272 - 3278

• The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers

  McCabe C. et al, (2011), Psychopharmacology, 217, 271 - 278

• The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers.

  McCabe C. et al, (2011), Psychopharmacology (Berl), 217, 271 - 278

• Short-term SSRI treatment remediates amygdala hyperactivity in depressed patients

  Godlewska BR. et al, (2011), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 21, S196 - S196

• Efficacy markers in depression.

  Harmer CJ. et al, (2011), J Psychopharmacol, 25, 1148 - 1158

• Efficacy markers in depression

  Harmer CJ. et al, (2011), Journal of Psychopharmacology, 25, 1148 - 1158

• Agomelatine facilitates positive versus negative affective processing in healthy volunteer models.

  Harmer CJ. et al, (2011), J Psychopharmacol, 25, 1159 - 1167

• Agomelatine facilitates positive versus negative affective processing in healthy volunteer models

  Harmer CJ. et al, (2011), Journal of Psychopharmacology, 25, 1159 - 1167

• A cognitive neuropsychological model of antidepressant drug action.

  Pringle A. et al, (2011), Prog Neuropsychopharmacol Biol Psychiatry, 35, 1586 - 1592

• SHORT-TERM SSRI TREATMENT REMEDIATES AMYGDALA HYPERACTIVITY IN DEPRESSED PATIENTS: A PLACEBO-CONTROLLED STUDY

  Godlewska BR. et al, (2011), JOURNAL OF PSYCHOPHARMACOLOGY, 25, A16 - A16

• INCREASED NEURAL PROCESSING OF REWARDING AND AVERSIVE FOOD STIMULI IN RECOVERED ANOREXIA NERVOSA

  McCabe C. et al, (2011), JOURNAL OF PSYCHOPHARMACOLOGY, 25, A32 - A32

• ERYTHROPOIETIN - A CANDIDATE TREATMENT FOR MOOD SYMPTOMS AND COGNITIVE DYSFUNCTION IN DEPRESSION

  Miskowiak KW. et al, (2011), JOURNAL OF PSYCHOPHARMACOLOGY, 25, A18 - A18

• DISRUPTED NEURAL ACTIVATION IN BIPOLAR PHENOTYPE DURING RISKY DECISION-MAKING

  Rock PL. et al, (2011), JOURNAL OF PSYCHOPHARMACOLOGY, 25, A14 - A14

• BRIEF COGNITIVE-BEHAVIOURAL TREATMENT NORMALISES INCREASED AMYGDALA RESPONSE TO THREAT IMAGES IN PATIENTS WITH PANIC DISORDER

  Reinecke A. et al, (2011), JOURNAL OF PSYCHOPHARMACOLOGY, 25, A62 - A62

• ATTENTIONAL BIAS MODIFICATION REDUCES DEPRESSIVE SYMPTOMS AND WAKING CORTISOL RISE IN PREVIOUSLY DEPRESSED PATIENTS

  Browning M. et al, (2011), JOURNAL OF PSYCHOPHARMACOLOGY, 25, A16 - A16

• SSRI administration reduces resting state functional connectivity in dorso-medial prefrontal cortex

  McCabe C. et al, (2011), Molecular Psychiatry, 16, 592 - 594

• SSRI administration reduces resting state functional connectivity in dorso-medial prefrontal cortex.

  McCabe C. et al, (2011), Mol Psychiatry, 16, 592 - 594

• The Effects of Quetiapine on Risky Decision-Making

  Rock PL. et al, (2011), BIOLOGICAL PSYCHIATRY, 69, 237S - 238S

• Short-term NK1 receptor antagonism and emotional processing in healthy volunteers.

  Pringle A. et al, (2011), Psychopharmacology (Berl), 215, 239 - 246

• Decreased Neural Response to Fear after a Short-term SSRI Treatment: A 3T Functional Magnetic Resonance Imaging Study

  Godlewska BR. et al, (2011), BIOLOGICAL PSYCHIATRY, 69, 163S - 164S

• Frontolimbic responses to emotional faces in young people at familial risk of depression.

  Mannie ZN. et al, (2011), J Affect Disord, 130, 127 - 132

• Neural correlates of the processing of self-referent emotional information in bulimia nervosa

  Pringle A. et al, (2011), Neuropsychologia

• Biases in emotional processing are associated with vulnerability to eating disorders over time.

  Pringle A. et al, (2011), Eat Behav, 12, 56 - 59

• A single dose of mirtazapine modulates neural responses to emotional faces in healthy people.

  Rawlings NB. et al, (2010), Psychopharmacology (Berl), 212, 625 - 634

• Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.

  Miskowiak KW. et al, (2010), Trials, 11

• The common adolescent bipolar phenotype shows positive biases in emotional processing.

  Rock PL. et al, (2010), Bipolar Disord, 12, 606 - 615

• Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers.

  Horder J. et al, (2010), Int J Neuropsychopharmacol, 13, 1103 - 1113

• Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients.

  Miskowiak KW. et al, (2010), Psychopharmacology (Berl), 210, 419 - 428

• Lateral prefrontal cortex mediates the cognitive modification of attentional bias.

  Browning M. et al, (2010), Biol Psychiatry, 67, 919 - 925

• NK1 receptor antagonism and emotional processing in healthy volunteers.

  Chandra P. et al, (2010), J Psychopharmacol, 24, 481 - 487

• Investigating vulnerability to eating disorders: biases in emotional processing.

  Pringle A. et al, (2010), Psychol Med, 40, 645 - 655

• The modification of attentional bias to emotional information: A review of the techniques, mechanisms, and relevance to emotional disorders.

  Browning M. et al, (2010), Cogn Affect Behav Neurosci, 10, 8 - 20

• Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment.

  McCabe C. et al, (2010), Biol Psychiatry, 67, 439 - 445

• Antidepressant drug action: a neuropsychological perspective.

  Harmer CJ., (2010), Depress Anxiety, 27, 231 - 233

• A functional magnetic resonance imaging study of verbal working memory in young people at increased familial risk of depression.

  Mannie ZN. et al, (2010), Biol Psychiatry, 67, 471 - 477

• Short-term NK1 receptor antagonism and emotional processing in healthy volunteers

  Pringle A. et al, (2010), Psychopharmacology, 1 - 8

• Low-dose tryptophan depletion in recovered depressed women induces impairments in autobiographical memory specificity.

  Haddad AD. et al, (2009), Psychopharmacology (Berl), 207, 499 - 508

• High-density negative ion treatment increases positive affective memory.

  Malcolm CP. et al, (2009), Psychol Med, 39, 1930 - 1932

• Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.

  Miskowiak KW. et al, (2009), Psychopharmacology (Berl), 207, 133 - 142

• Short-term antidepressant treatment modulates amygdala response to happy faces.

  Norbury R. et al, (2009), Psychopharmacology (Berl), 206, 197 - 204

• NK1 receptor antagonism and the neural processing of emotional information in healthy volunteers.

  McCabe C. et al, (2009), Int J Neuropsychopharmacol, 12, 1261 - 1274

• Effect of acute antidepressant administration on negative affective bias in depressed patients.

  Harmer CJ. et al, (2009), Am J Psychiatry, 166, 1178 - 1184

• The role of serotonin in nonnormative risky choice: the effects of tryptophan supplements on the "reflection effect" in healthy adult volunteers.

  Murphy SE. et al, (2009), J Cogn Neurosci, 21, 1709 - 1719

• Neural representation of reward in recovered depressed patients.

  McCabe C. et al, (2009), Psychopharmacology (Berl), 205, 667 - 677

• Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action.

  Harmer CJ. et al, (2009), Br J Psychiatry, 195, 102 - 108

• Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers.

  Horder J. et al, (2009), Psychopharmacology (Berl), 205, 85 - 91

• Effect of a single dose of citalopram on amygdala response to emotional faces.

  Murphy SE. et al, (2009), Br J Psychiatry, 194, 535 - 540

• Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers.

  Di Simplicio M. et al, (2009), J Psychopharmacol, 23, 241 - 248

• Memory impairment in young women at increased risk of depression: influence of cortisol and 5-HTT genotype.

  Mannie ZN. et al, (2009), Psychol Med, 39, 757 - 762

• Early effects of mirtazapine on emotional processing.

  Arnone D. et al, (2009), Psychopharmacology (Berl), 203, 685 - 691

• Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers.

  Murphy SE. et al, (2009), Int J Neuropsychopharmacol, 12, 169 - 179

• Risk for depression and neural responses to fearful facial expressions of emotion.

  Chan SW. et al, (2009), Br J Psychiatry, 194, 139 - 145

• NK1 receptor antagonism and the neural processing of emotional information in healthy volunteers

  McCabe C. et al, (2009), International Journal of Neuropsychopharmacology, 1 - 14

• The effects of reboxetine on emotional processing in healthy volunteers: an fMRI study.

  Norbury R. et al, (2008), Mol Psychiatry, 13, 1011 - 1020

• Serotonin and emotional processing: does it help explain antidepressant drug action?

  Harmer CJ., (2008), Neuropharmacology, 55, 1023 - 1028

• Risk for depression is associated with neural biases in emotional categorisation.

  Chan SW. et al, (2008), Neuropsychologia, 46, 2896 - 2903

• Dissociable effects of acute antidepressant drug administration on subjective and emotional processing measures in healthy volunteers.

  Harmer CJ. et al, (2008), Psychopharmacology (Berl), 199, 495 - 502

• Direct effects of diazepam on emotional processing in healthy volunteers.

  Murphy SE. et al, (2008), Psychopharmacology (Berl), 199, 503 - 513

• Bilateral generic working memory circuit requires left-lateralized addition for verbal processing.

  Ray MK. et al, (2008), Cereb Cortex, 18, 1421 - 1428

• Affective modulation of anterior cingulate cortex in young people at increased familial risk of depression.

  Mannie ZN. et al, (2008), Br J Psychiatry, 192, 356 - 361

• Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration.

  Miskowiak K. et al, (2008), Neuropsychopharmacology, 33, 611 - 618

• Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration.

  Miskowiak K. et al, (2008), Exp Brain Res, 184, 313 - 321

• Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action.

  Miskowiak K. et al, (2007), Biol Psychiatry, 62, 1244 - 1250

• Effects of acute tyrosine depletion on subjective craving and selective processing of smoking-related cues in abstinent cigarette smokers.

  Munafò MR. et al, (2007), J Psychopharmacol, 21, 805 - 814

• Impaired emotional categorisation in young people at increased familial risk of depression.

  Mannie ZN. et al, (2007), Neuropsychologia, 45, 2975 - 2980

• Single dose antidepressant administration modulates the neural processing of self-referent personality trait words.

  Miskowiak K. et al, (2007), Neuroimage, 37, 904 - 911

• Highly neurotic never-depressed students have negative biases in information processing.

  Chan SW. et al, (2007), Psychol Med, 37, 1281 - 1291

• A single dose of citalopram increases fear recognition in healthy subjects.

  Browning M. et al, (2007), J Psychopharmacol, 21, 684 - 690

• Effects of alpha-lactalbumin on emotional processing in healthy women.

  Scrutton H. et al, (2007), J Psychopharmacol, 21, 519 - 524

• Short-term antidepressant treatment and facial processing. Functional magnetic resonance imaging study.

  Norbury R. et al, (2007), Br J Psychiatry, 190, 531 - 532

• Increased waking salivary cortisol levels in young people at familial risk of depression.

  Mannie ZN. et al, (2007), Am J Psychiatry, 164, 617 - 621

• Erythropoietin enhances hippocampal response during memory retrieval in humans.

  Miskowiak K. et al, (2007), J Neurosci, 27, 2788 - 2792

• Emotional bias and waking salivary cortisol in relatives of patients with major depression.

  Le Masurier M. et al, (2007), Psychol Med, 37, 403 - 410

• Emotional bias and waking salivary cortisol in relatives of patients with major depression

  Masurier ML. et al, (2007), Psychological Medicine, 37, 403 - 410

• Sex differences in the effect of acute tryptophan depletion on declarative episodic memory: a pooled analysis of nine studies.

  Sambeth A. et al, (2007), Neurosci Biobehav Rev, 31, 516 - 529

• Tryptophan supplementation induces a positive bias in the processing of emotional material in healthy female volunteers.

  Murphy SE. et al, (2006), Psychopharmacology (Berl), 187, 121 - 130

• Antidepressant drug treatment modifies the neural processing of nonconscious threat cues.

  Harmer CJ. et al, (2006), Biol Psychiatry, 59, 816 - 820

• 5HT(3) antagonism abolishes the emotion potentiated startle effect in humans.

  Harmer CJ. et al, (2006), Psychopharmacology (Berl), 186, 18 - 24

• Early morning salivary cortisol is not associated with extraversion

  Munafò MR. et al, (2006), Personality and Individual Differences, 40, 395 - 400

• Lack of effect of tyrosine depletion on mood in recovered depressed women.

  McTavish SF. et al, (2005), Neuropsychopharmacology, 30, 786 - 791

• Enhanced early morning salivary cortisol in neuroticism.

  Portella MJ. et al, (2005), Am J Psychiatry, 162, 807 - 809

• Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms.

  Hayward G. et al, (2005), Biol Psychiatry, 57, 517 - 524

• Neuroticism as a psychological vulnerability factor for mood disorders

  Portella MJ. et al, (2004), JOURNAL OF PSYCHOPHARMACOLOGY, 18, A12 - A12

• Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition.

  Harmer CJ. et al, (2004), Am J Psychiatry, 161, 1256 - 1263

• The role of the anterior cingulate cortex in the counting Stroop task.

  Hayward G. et al, (2004), Exp Brain Res, 154, 355 - 358

• Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression.

  Bhagwagar Z. et al, (2004), Am J Psychiatry, 161, 166 - 168

• Acute reboxetine administration increases plasma and salivary cortisol.

  Hill SA. et al, (2003), J Psychopharmacol, 17, 273 - 275

• Acute administration of nutritionally sourced tryptophan increases fear recognition.

  Attenburrow MJ. et al, (2003), Psychopharmacology (Berl), 169, 104 - 107

• Tryptophan depletion decreases the recognition of fear in female volunteers.

  Harmer CJ. et al, (2003), Psychopharmacology (Berl), 167, 411 - 417

• Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity.

  Harmer CJ. et al, (2003), Am J Psychiatry, 160, 990 - 992

• Contrasting effects of citalopram and reboxetine on waking salivary cortisol.

  Harmer CJ. et al, (2003), Psychopharmacology (Berl), 167, 112 - 114

• Effects of a branched-chain amino acid drink in mania.

  Scarna A. et al, (2003), Br J Psychiatry, 182, 210 - 213

• Antidepressants and emotional processing

  Harmer CJ. et al, (2003), Neuropsychopharmacology, 28, 1384 - 1385

• Acute SSRI administration affects the processing of social cues in healthy volunteers.

  Harmer CJ. et al, (2003), Neuropsychopharmacology, 28, 148 - 152

• Acute administration of citalopram facilitates memory consolidation in healthy volunteers.

  Harmer CJ. et al, (2002), Psychopharmacology (Berl), 163, 106 - 110

• A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function.

  Gijsman HJ. et al, (2002), Psychopharmacology (Berl), 160, 192 - 197

• Enhanced recognition of disgust in bipolar illness.

  Harmer CJ. et al, (2002), Biol Psychiatry, 51, 298 - 304

• Sustained attention deficit in bipolar disorder is not a working memory impairment in disguise.

  Harmer CJ. et al, (2002), Neuropsychologia, 40, 1586 - 1590

• Effect of branch chain amino acids supplemented with tryptophan on tyrosine availability and plasma prolactin.

  Scarnà A. et al, (2002), Psychopharmacology (Berl), 159, 222 - 223

• Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness.

  McTavish SF. et al, (2001), Br J Psychiatry, 179, 356 - 360

• Administration of the beta-adrenoceptor blocker propranolol impairs the processing of facial expressions of sadness.

  Harmer CJ. et al, (2001), Psychopharmacology (Berl), 154, 383 - 389

• Tyrosine depletion attenuates dopamine function in healthy volunteers.

  Harmer CJ. et al, (2001), Psychopharmacology (Berl), 154, 105 - 111

• Transcranial magnetic stimulation of medial-frontal cortex impairs the processing of angry facial expressions.

  Harmer CJ. et al, (2001), Nat Neurosci, 4, 17 - 18

• Repetitive transcranial magnetic stimulation to right prefrontal cortex does not modulate the psychostimulant effects of amphetamine.

  Clark L. et al, (2000), Int J Neuropsychopharmacol, 3, 297 - 302

• Oxford Lithium Trial (OxLith): a randomised, double-blind placebo-controlled study of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorde

  Geddes JR. et al, Trials

Recent Publications

• Vortioxetine reduces BOLD signal during performance of the N-back working memory task: a randomised neuroimaging trial in remitted depressed patients and healthy controls.

  Smith J. et al, (2017), Mol Psychiatry
• Variation in the recall of socially rewarding information and depressive symptom severity: a prospective cohort study.

  Lewis G. et al, (2017), Acta Psychiatr Scand, 135, 489 - 498
• How do antidepressants work? New perspectives for refining future treatment approaches.

  Harmer CJ. et al, (2017), Lancet Psychiatry, 4, 409 - 418
• Differences in neural and cognitive response to emotional faces in middle-aged dizygotic twins at familial risk of depression.

  Miskowiak KW. et al, (2017), Psychol Med, 1 - 13
• The effects of medication and current mood upon facial emotion recognition: findings from a large bipolar disorder cohort study.

  Bilderbeck AC. et al, (2017), J Psychopharmacol, 31, 320 - 326